Report: Diabetes Dx market to hit $32B by 2017

It may be obvious to point out that the worldwide explosion of diabetes is expanding the market for diagnostics to assess the disease. But Global Industry Analysts is offering something new by quantifying how much that expansion will be. The firm predicts in a new report that the global diabetes diagnostics market will reach $32 billion by 2017. That increase will be driven by rising disease incidence, heightened awareness, and a two-year recovery in the sector after a recession-driven slowdown in 2008 and 2009. Improved diagnostic technology also has helped, according to the report. Companies that make blood glucose meters and monitors, blood glucose test strips, lancets and related equipment all stand to gain in the coming years, GIA notes. Release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.